Reuters: Hot Stocks: BRIEF-Cell Therapeutics jumps in premarket after opaxiotm gets orphan drug designation

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Cell Therapeutics jumps in premarket after opaxiotm gets orphan drug designation Oct 2nd 2012, 11:47 NEW YORK | Tue Oct 2, 2012 7:47am EDT NEW YORK Oct 2 (Reuters) - Cell Therapeutics Inc : * Jumps 23.3 percent to $2.75 in premarket after opaxiotm gets orphan drug designation from U.S. Food and Drug Administration for malignant brain cancer

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions